Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases

Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases

The survival of patients with head and neck squamous cancer with locoregional recurrence is short if salvage surgery or radiation cannot be performed. Systemic chemotherapy based on platinum salts and cetuximab produces only partial and transient responses. Immune checkpoint inhibitors (i.e., nivolu...

Full description

Bibliographic Details
Main Authors: Aline Houessinon, Aurélie Moreira, Jérèmie Bettoni, Marine Schoonaker, Chloé Sauzay, Antoine Galmiche, Alexandre Coutte, Aurélie Biet, Claude Krzisch, Bruno Chauffert
Format: Article
Language:English
Published: Karger Publishers 2020-07-01
Series:Case Reports in Oncology
Subjects:
head and neck cancer
nivolumab
intratumoral chemotherapy
abscopal-like effect
Online Access:https://www.karger.com/Article/FullText/507986

Internet

https://www.karger.com/Article/FullText/507986

Similar Items